THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES
The invention relates to a thiophene derivative of the following general formula (I) or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof, and the use of same as a medicament especially for the treatment and/or prevention of diabe...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FAVERIEL, LAUREN R LENA, GERSANDE R RAYNAL, SOPHIE N KERGOAT, MICHELINE R AUTIER, VALERIE LEPIFRE, FRANCK F AUDET, ANNICK M CHARON, CHRISTINE G |
| description | The invention relates to a thiophene derivative of the following general formula (I) or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof, and the use of same as a medicament especially for the treatment and/or prevention of diabetes, the complications thereof and/or associated pathologies, advantageously type 2 diabetes and hyperglycemia.
La présente invention concerne un dérivé thiophène de formule générale I suivante (I) ou un énantiomère, diastéréoisomère, hydrate, solvate, tautomère, mélange racémique ou sel pharmaceutiquement acceptable de celui-ci et son utilisation à titre de médicament en particulier destiné au traitement et/ou à la prévention dudiabète, de ses complications et/ou des pathologies associés, avantageusement du diabète de type 2 et de l'hyperglycémie. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2879053C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2879053C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2879053C3</originalsourceid><addsrcrecordid>eNrjZDAP8fD0D_Bw9XNVcHEN8gxzDPEMcw1WCA12dVHw9FMI8XBVCAlydQzxdfULUfB3U3DxdHRyDXEN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhbmlgamxs7GhFUAAJ2AJ0U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES</title><source>esp@cenet</source><creator>FAVERIEL, LAUREN R ; LENA, GERSANDE R ; RAYNAL, SOPHIE N ; KERGOAT, MICHELINE R ; AUTIER, VALERIE ; LEPIFRE, FRANCK F ; AUDET, ANNICK M ; CHARON, CHRISTINE G</creator><creatorcontrib>FAVERIEL, LAUREN R ; LENA, GERSANDE R ; RAYNAL, SOPHIE N ; KERGOAT, MICHELINE R ; AUTIER, VALERIE ; LEPIFRE, FRANCK F ; AUDET, ANNICK M ; CHARON, CHRISTINE G</creatorcontrib><description>The invention relates to a thiophene derivative of the following general formula (I) or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof, and the use of same as a medicament especially for the treatment and/or prevention of diabetes, the complications thereof and/or associated pathologies, advantageously type 2 diabetes and hyperglycemia.
La présente invention concerne un dérivé thiophène de formule générale I suivante (I) ou un énantiomère, diastéréoisomère, hydrate, solvate, tautomère, mélange racémique ou sel pharmaceutiquement acceptable de celui-ci et son utilisation à titre de médicament en particulier destiné au traitement et/ou à la prévention dudiabète, de ses complications et/ou des pathologies associés, avantageusement du diabète de type 2 et de l'hyperglycémie.</description><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210209&DB=EPODOC&CC=CA&NR=2879053C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210209&DB=EPODOC&CC=CA&NR=2879053C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FAVERIEL, LAUREN R</creatorcontrib><creatorcontrib>LENA, GERSANDE R</creatorcontrib><creatorcontrib>RAYNAL, SOPHIE N</creatorcontrib><creatorcontrib>KERGOAT, MICHELINE R</creatorcontrib><creatorcontrib>AUTIER, VALERIE</creatorcontrib><creatorcontrib>LEPIFRE, FRANCK F</creatorcontrib><creatorcontrib>AUDET, ANNICK M</creatorcontrib><creatorcontrib>CHARON, CHRISTINE G</creatorcontrib><title>THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES</title><description>The invention relates to a thiophene derivative of the following general formula (I) or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof, and the use of same as a medicament especially for the treatment and/or prevention of diabetes, the complications thereof and/or associated pathologies, advantageously type 2 diabetes and hyperglycemia.
La présente invention concerne un dérivé thiophène de formule générale I suivante (I) ou un énantiomère, diastéréoisomère, hydrate, solvate, tautomère, mélange racémique ou sel pharmaceutiquement acceptable de celui-ci et son utilisation à titre de médicament en particulier destiné au traitement et/ou à la prévention dudiabète, de ses complications et/ou des pathologies associés, avantageusement du diabète de type 2 et de l'hyperglycémie.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAP8fD0D_Bw9XNVcHEN8gxzDPEMcw1WCA12dVHw9FMI8XBVCAlydQzxdfULUfB3U3DxdHRyDXEN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhbmlgamxs7GhFUAAJ2AJ0U</recordid><startdate>20210209</startdate><enddate>20210209</enddate><creator>FAVERIEL, LAUREN R</creator><creator>LENA, GERSANDE R</creator><creator>RAYNAL, SOPHIE N</creator><creator>KERGOAT, MICHELINE R</creator><creator>AUTIER, VALERIE</creator><creator>LEPIFRE, FRANCK F</creator><creator>AUDET, ANNICK M</creator><creator>CHARON, CHRISTINE G</creator><scope>EVB</scope></search><sort><creationdate>20210209</creationdate><title>THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES</title><author>FAVERIEL, LAUREN R ; LENA, GERSANDE R ; RAYNAL, SOPHIE N ; KERGOAT, MICHELINE R ; AUTIER, VALERIE ; LEPIFRE, FRANCK F ; AUDET, ANNICK M ; CHARON, CHRISTINE G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2879053C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>FAVERIEL, LAUREN R</creatorcontrib><creatorcontrib>LENA, GERSANDE R</creatorcontrib><creatorcontrib>RAYNAL, SOPHIE N</creatorcontrib><creatorcontrib>KERGOAT, MICHELINE R</creatorcontrib><creatorcontrib>AUTIER, VALERIE</creatorcontrib><creatorcontrib>LEPIFRE, FRANCK F</creatorcontrib><creatorcontrib>AUDET, ANNICK M</creatorcontrib><creatorcontrib>CHARON, CHRISTINE G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FAVERIEL, LAUREN R</au><au>LENA, GERSANDE R</au><au>RAYNAL, SOPHIE N</au><au>KERGOAT, MICHELINE R</au><au>AUTIER, VALERIE</au><au>LEPIFRE, FRANCK F</au><au>AUDET, ANNICK M</au><au>CHARON, CHRISTINE G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES</title><date>2021-02-09</date><risdate>2021</risdate><abstract>The invention relates to a thiophene derivative of the following general formula (I) or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof, and the use of same as a medicament especially for the treatment and/or prevention of diabetes, the complications thereof and/or associated pathologies, advantageously type 2 diabetes and hyperglycemia.
La présente invention concerne un dérivé thiophène de formule générale I suivante (I) ou un énantiomère, diastéréoisomère, hydrate, solvate, tautomère, mélange racémique ou sel pharmaceutiquement acceptable de celui-ci et son utilisation à titre de médicament en particulier destiné au traitement et/ou à la prévention dudiabète, de ses complications et/ou des pathologies associés, avantageusement du diabète de type 2 et de l'hyperglycémie.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2879053C |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | THIOPHENE DERIVATIVES USED IN THE TREATMENT OF DIABETES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A52%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FAVERIEL,%20LAUREN%20R&rft.date=2021-02-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2879053C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |